1. Medtech Insight
  2. >>Policy & Regulation

Recall Of Medtronic’s HeartWare Pump Kits Labeled Class I By FDA; Deaths, Injuries Reported

 
• By Shawn M. Schmitt

The recall of the kit, which is part of the HeartWare HVAD System, was affixed with the US agency’s highest risk classification on 1 March.

Sign of Medtronic at Canada Headquarters in Brampton, Ontario, Canada.

The US Food and Drug Administration has classified a recall of Medtronic PLC’s HeartWare Ventricular Assist Device (HVAD) Pump Implant Kits as high-risk class I. Two deaths and 19 serious injuries have been reported, the agency said on 1 March.

The FDA says “the device may fail to initially start, restart or have a delay in restarting after the pump...

More from Recalls

More from Policy & Regulation